Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 643 of 1,261
  1. US 9598492

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  2. US 9598414

    Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders

    DAYA DRUG DISCOVERIES, INC. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  3. US 9596855

    Small molecule inhibitors of biofilm formation and the novel use of previously identified compounds for inhibition of biofilm formation and applications for drug therapy and medical device coating

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  4. US 9598697

    Recombinant bacterium to decrease tumor growth

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  5. US 9598703

    Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  6. US 9598694

    Micro-RNAs involved in macular degeneration

    The Board of Regents of the University of Texas System · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  7. US 9598471

    Bacteriocin with novel activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  8. US 9598693

    Oligomeric compounds and compositions for the use in modulation of micrornas

    Ionis Pharmaceuticals, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  9. US 9598432

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  10. US 9598424

    Heteroarylamide inhibitors of TBK1

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  11. US 9598441

    Therapeutic compounds and methods

    The United States of America as represented by the Department of Veteran Affairs · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  12. US 9598495

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  13. US 9598401

    Substituted heteroaryl compounds and methods of use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  14. US 9598400

    Substituted quinoline compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  15. US 9598398

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  16. US 9598395

    Premature-termination-codons readthrough compounds

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  17. US 9598375

    Substituted imidazole derivatives and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  18. US 9597427

    Radioactive bone cement

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  19. US 9597372

    Vault complexes for cytokine delivery

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  20. US 9597357

    T cell modifying compounds and uses thereof

    Sangamo Biosciences, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  21. US 9597353

    Redox signaling gel formulation

    Reoxcyn Discoveries Group, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  22. US 9597336

    Therapy for treatment of chronic degenerative brain diseases and nervous system injury

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  23. US 9597276

    Composition for the prophylaxis of candidiasis

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NTLAB-SC” · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  24. US 9597302

    Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation

    Heart Rhythm Solutions, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.